Focus Features released the trailer for Robert Eggers' adaptation of "Nosferatu" on Monday. The film is in theaters Christmas ...

"You've had these spells since childhood. Tell me what you can, from the beginning," Willem Dafoe's character tells Lily-Rose Depp's, Ellen Hutter, before she recounts her horrific memories.

The cause of death for baseball legend Pete Rose has been revealed. Rose, MLB’s all-time hits leader who was banned from baseball in 1989 for gambling on Cincinnati Reds games while he served ...

Skarsgård's vampire character is a "force more powerful than evil" in the film, opening in theaters on December 25th. Bill ...

Cincinnati Reds great Pete Rose died at his Las Vegas home Monday because of a serious heart condition, a Nevada coroner said Tuesday. Rose, 83, suffered from hypertensive and atherosclerotic ...

Rose essential oil may have possible health benefits, from easing pain to managing anxiety and stress. However, more research is necessary to determine its benefits. Rose oil is derived from the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand, which should help the company widen its share of the booming weight-loss drug market.

Correction/clarification: An earlier version of this story incorrectly reported Pete Rose’s Hall of Fame status and mischaracterized players who were part of the Reds’ Big Red Machine.

Eli Lilly’s two weight loss drugs have become blockbusters, bringing in more than $1 billion in annual revenue. Demand is growing in this market, but so is competition. These players ...

Oct. 2 (UPI) --Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Indiana expected to open in late 2027.

(This story was updated to add new information.)Eli Lilly and Co. is investing an additional $4.5 billion into the LEAP Research and Innovation District in Lebanon, bringing the drug company's ...